Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$66.02 - $79.71 $5.31 Million - $6.41 Million
-80,450 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$63.34 - $74.11 $1.81 Million - $2.12 Million
28,600 Added 55.16%
80,450 $5.91 Million
Q3 2021

Nov 05, 2021

SELL
$68.67 - $84.02 $10.8 Million - $13.2 Million
-156,780 Reduced 75.15%
51,850 $3.57 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $995,180 - $1.09 Million
12,460 Added 6.35%
208,630 $17.6 Million
Q1 2021

May 07, 2021

SELL
$76.02 - $100.5 $337,528 - $446,220
-4,440 Reduced 2.21%
196,170 $15.9 Million
Q4 2020

Feb 01, 2021

BUY
$80.74 - $97.7 $2.11 Million - $2.56 Million
26,160 Added 15.0%
200,610 $17.4 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $4.18 Million - $6.14 Million
-56,410 Reduced 24.43%
174,450 $18.1 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $1.29 Million - $1.76 Million
20,490 Added 9.74%
230,860 $16.9 Million
Q4 2019

Jan 24, 2020

SELL
$73.04 - $95.72 $546,339 - $715,985
-7,480 Reduced 3.43%
210,370 $18.4 Million
Q3 2019

Oct 21, 2019

BUY
$72.82 - $86.52 $1.75 Million - $2.08 Million
23,990 Added 12.37%
217,850 $16.2 Million
Q2 2019

Jul 23, 2019

BUY
$73.52 - $88.7 $810,925 - $978,361
11,030 Added 6.03%
193,860 $16.5 Million
Q1 2019

Apr 29, 2019

SELL
$63.56 - $88.17 $1.94 Million - $2.69 Million
-30,500 Reduced 14.3%
182,830 $15.7 Million
Q4 2018

Jan 17, 2019

BUY
$58.5 - $69.94 $1.19 Million - $1.43 Million
20,410 Added 10.58%
213,330 $13.6 Million
Q3 2018

Oct 31, 2018

BUY
$61.75 - $74.23 $1.86 Million - $2.24 Million
30,120 Added 18.5%
192,920 $13.3 Million
Q2 2018

Jul 18, 2018

SELL
$60.85 - $83.98 $823,300 - $1.14 Million
-13,530 Reduced 7.67%
162,800 $10.9 Million
Q1 2018

May 09, 2018

BUY
$83.06 - $100.98 $14.6 Million - $17.8 Million
176,330 New
176,330 $14.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Nippon Life Global Investors Americas, Inc. Portfolio

Follow Nippon Life Global Investors Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.